Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Bluejay Diagnostics Q2 EPS $(0.10)

Bluejay Diagnostics Q2 EPS $(0.10)

Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(0.10) per share.

byMichael Horton

July 26, 2022

1 minute read

Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(0.10) per share.

Cowen & Co. Maintains Market Perform on Domino’s Pizza, Lowers Price Target to $362

By Benzinga Newsdesk

September 27, 5:09 AM

Cowen & Co. analyst Andrew Charles maintains Domino's Pizza (NYSE:DPZ) with a Market Perform and lowers the price target from $410 to $362.

DPZ

Health Care Company Zevra Therapeutics Announces Merger With Acer Therapeutics

By Benzinga Insights

August 31, 11:10 AM

Zevra Therapeutics (NASDAQ:ZVRA) has announced a merger with Acer Therapeutics (NASDAQ:ACER) that is expected to be completed in…

ACER

Hillenbrand Raises Quarterly Dividend From $0.2175/Share To $0.22/Share

By Michael Horton

December 7, 6:46 PM

The board of directors of Hillenbrand, Inc. (NYSE:HI) has declared a regular quarterly cash dividend of $0.22 per share on the company's common stock. On an annualized basis, this is an increase

Apple Faces Potential $14B Tax Bill as EU Court Adviser Cites Legal Flaws in Previous Ruling

By Anusuya Lahiri

November 9, 10:31 AM

Apple Inc (NASDAQ: AAPL) could be liable to a €13 billion ($14 billion)

AAPL

Bluejay Diagnostics Q2 EPS $(0.10)

Related Posts

Cowen & Co. Maintains Market Perform on Domino’s Pizza, Lowers Price Target to $362

Health Care Company Zevra Therapeutics Announces Merger With Acer Therapeutics

Hillenbrand Raises Quarterly Dividend From $0.2175/Share To $0.22/Share

Apple Faces Potential $14B Tax Bill as EU Court Adviser Cites Legal Flaws in Previous Ruling